Baxter International (BAX) Gross Margin (2009 - 2026)
Baxter International's (BAX) quarterly Gross Margin came in at 34.86% in Q2 2026, down 40.0% year-over-year from 58.11% in Q2 2025, and up 5.69% quarter-over-quarter from 32.99% in Q1 2026.
Analysis
Baxter International (BAX) Gross Margin (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Gross Margin for 18 consecutive years, with 34.86% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin fell 40.0% year-over-year to 34.86% in Q2 2026; TTM through Jun 2026 was 34.02%, a 129.0% decrease from a year earlier, with the FY2025 full-year figure at 30.05%, down 741.0% from the prior year.
- Gross Margin was 34.86% for Q2 2026 at Baxter International, up from 32.99% in the prior quarter.
- Over five years, Gross Margin peaked at 40.63% in Q3 2023 and troughed at 28.96% in Q3 2022.
- A 5-year average of 36.61% and a median of 37.6% in 2022 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin plunged 1199 bps in 2022 and surged 1168 bps in 2023, its largest moves.
- Over 5 years, Gross Margin stood at 37.06% in 2022, then climbed by 9 bps to 40.31% in 2023, then declined by 14 bps to 34.83% in 2024, then climbed by 1 bps to 35.27% in 2025, then decreased by 1 bps to 34.86% in 2026.
- The last three Gross Margin figures came in at 34.86% (Q2 2026), 32.99% (Q1 2026), and 35.27% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 46.46% |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 28.82% |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 37.74% |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 34.86% |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 28.75% |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 42.55% |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 18.24% |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 2.65% |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.86% |
| Mar 31, 2026 | 32.99% |
| Jun 30, 2025 | 35.27% |
| Mar 31, 2025 | 32.80% |
| Dec 31, 2024 | 34.83% |
| Sep 30, 2024 | 38.27% |
| Jun 30, 2024 | 38.27% |
| Mar 31, 2024 | 38.59% |
| Dec 31, 2023 | 40.31% |
| Sep 30, 2023 | 40.63% |
| Jun 30, 2023 | 39.75% |
| Mar 31, 2023 | 39.49% |
| Dec 31, 2022 | 37.06% |
| Sep 30, 2022 | 28.96% |
| Jun 30, 2022 | 38.15% |
| Mar 31, 2022 | 35.47% |
| Dec 31, 2021 | 35.50% |
| Sep 30, 2021 | 40.95% |
| Jun 30, 2021 | 39.80% |
| Mar 31, 2021 | 38.87% |